Skip to main content
SpringerLink
Log in

Older Age Bipolar Disorder and Substance Use

  • Chapter
  • First Online:
Bipolar Disorder in Older Age Patients

  • 1142 Accesses

Abstract

The devastating impact of substance use disorders (SUDs) among older adults has only recently attracted the attention of researchers, clinicians, and the general public. Despite the evidence that alcohol and other SUDs affect nearly 1 in 5 older adults, there has been limited examination of these areas in the substance abuse or gerontology literature. Bearing in mind the paucity of research on the screening, assessment, and treatment protocols for older adults with bipolar disorder and coexisting SUD, in this chapter, we outline the state of current knowledge and where possible, make clinical recommendations on the assessment and management of SUDs among older adults with bipolar disorder. Adults with bipolar disorder (compared to other psychiatric disorders) have the highest rate of alcohol use disorder [3]. With the predicted dramatic growth of the aging population, as well as more geriatric patients in outpatient opioid maintenance programs both due to the aging of patients first enrolled in the 1990s and due to patients with prescription opioid misuse in later life, the need and demand for effective, comprehensive mental health services for older adults with psychiatric illness and substance use disorders will continue to grow. Other disorders, such as benzodiazepines, cannabis, and psychostimulants are also described, with future directions for research outlined.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Regler DA, Farmer MD, Rae D et al. Comorbidity of mental disorders with alcohol and drug abuse. JAMA. 1990;264(19):2511--8.

    Google Scholar 

  2. Substance abuse among older adults. Treatment Improvement Protocol Series Substance Abuse and Mental Health Services Administration (SAMHA) http://store.samhsa.gov/product/TIP-26-Substance-Abuse-Among-Older-Adults/SMA12-3918.

  3. Grey C, Hall PB. Considerations of prescription opioid abuse and misuse among older adults in West Virginia—an under-recognized population at risk. W V Med J. 2016;112(3):42–7.

    PubMed  Google Scholar 

  4. Dallaspezia S, Suzuki M, Benedetti F. Chronobiological therapy for mood disorders. Curr Psychiatry Rep. 2015;17(12):95.

    Article  PubMed  Google Scholar 

  5. Grant BF, Stinson FS, Dawson DA, et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorder. Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2004;61:807–16.

    Article  PubMed  Google Scholar 

  6. Hasin DS, Stinson FS, Ogburn E, et al. Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the United States. Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry. 2007;64:830–42.

    Article  PubMed  Google Scholar 

  7. Merikangas KR, Akiskal HS, Angst J, et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2007;64:543–52.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Cassidy F, Ahearn EP, Carroll BJ. Substance abuse in bipolar disorder. Bipolar Disord. 2001;3:194–200.

    Google Scholar 

  9. Sajatovic M, Blow FC, Ignacio RV. Psychiatric comorbidity in older adults with bipolar disorder. Int J Geriatr Psychiatry. 2006;21:582–7.

    Article  PubMed  Google Scholar 

  10. Goldstein B, Velyvis V, Parkh V. The association between moderate alcohol use and illness severity: a preliminary report. J Clin Psychiatry. 2006;67:102–6.

    Article  PubMed  Google Scholar 

  11. Kilbourne AM, Haas GL, Mulsant BH, Bauer MS, Pincus HA. Concurrent psychiatric diagnoses by age and race among persons with bipolar disorder. Psychiatr Serv. 2004;55(8):931–3.

    Article  PubMed  Google Scholar 

  12. Dols A, Rhebergen D, Beekman A, et al. Psychiatric and medical comorbidities: results from a bipolar elderly cohort study. Am J Geriatr Psychiatry. 2014;22:1066–74.

    Article  PubMed  Google Scholar 

  13. Depp CA, Jeste DV. Bipolar disorder in older adults: a critical review. Bipolar Disord. 2004;6(5):343–67.

    Article  PubMed  Google Scholar 

  14. Marsh WK, Ketter TA, Crawford SL, Johnson JV, Kroll-Desrosiers AR, Rothschild AJ. Progression of female reproductive stages associated with bipolar illness exacerbation. Bipolar Disord. 2012;14(5):515–26.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Weiss RD, Ostacher MDJ, Otto M. Does recovery from substance use disorder matter in patients with bipolar disorder? J Clin Psychiatry. 2005;61:361–7.

    Article  Google Scholar 

  16. Sonne SC, Brady KT, Morton WA. Substance abuse and bipolar affective disorder. J Nerv Ment Dis. 1994;182:349–52.

    Article  CAS  PubMed  Google Scholar 

  17. Altshuler LL, Kupka RW, Hellemann G, Frye MA, Sugar CA, McElroy SL, Nolen WA, Grunze H, Leverich GS, Keck PE, Zermeno M, Post RM, Suppes T. Gender and depressive symptoms in 711 patients with bipolar disorder evaluated prospectively in the Stanley Foundation bipolar treatment outcome network. Am J Psychiatry. 2010;167(6):708–15.

    Article  PubMed  Google Scholar 

  18. Kerridge BT, Saha TD, Chou SP, Zhang H, Jung J, Ruan WJ, Smith SM, Huang B, Hasin DS. Gender and nonmedical prescription opioid use and DSM-5 nonmedical prescription opioid use disorder. Results from the National Epidemiologic Survey on Alcohol and Related Conditions—III. Drug Alcohol Depend. 2015;1(156):47–56.

    Article  Google Scholar 

  19. Jarvis GE. Changing psychiatric perception of African-Americans with affective disorders. J Nerv Ment Dis. 2012;200(12):1031–40.

    Article  PubMed  Google Scholar 

  20. Schaffer A, Isometsä ET, Azorin JM, Cassidy F, Goldstein T, Rihmer Z, Sinyor M, Tondo L, Moreno DH, Turecki G, Reis C, Kessing LV, Ha K, Weizman A, Beautrais A, Chou YH, Diazgranados N, Levitt AJ, Zarate CA Jr, Yatham L. A review of factors associated with greater likelihood of suicide attempts and suicide deaths in bipolar disorder: part II of a report of the International Society for Bipolar Disorders Task Force on Suicide in Bipolar Disorder. Aust N Z J Psychiatry. 2015;49(11):1006–20.

    Article  PubMed  Google Scholar 

  21. Gonzalez JM, Bowden CL, Berman N, Frank E, Bauer MS, Kogan JN, Alegría M, Miklowitz DJ. One-year treatment outcomes of African-American and Hispanic patients with bipolar I or II disorder in STEP BD. Psychiatr Serv. 2010;61(2):164–72.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Johnson KR, Johnson SL. Inadequate treatment of black Americans with bipolar disorder. Psychiatr Serv. 2014;65(2):255–8.

    Article  PubMed  Google Scholar 

  23. Kemp DE, Sylvia LG, Calabrese JR, Nierenberg AA, Thase ME, Reilly-Harrington NA, Ostacher MJ, Leon AC, Ketter TA, Friedman ES, Bowden CL, Rabideau DJ, Pencina M, Iosifescu DV, LiTMUS Study Group. General medical burden in bipolar disorder: findings from the LiTMUS comparative effectiveness trial. Acta Psychiatr Scand. 2014;129(1):24–34.

    Article  CAS  PubMed  Google Scholar 

  24. Sentell T, Unick GJ, Ahn HJ, Braun KL, Miyamura J, Shumway M. Illness severity and psychiatric hospitalization rates among Asian Americans and Pacific Islanders. Psychiatr Serv. 2013;64(11):1095–102.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Fleck DE, Keck PE Jr, Corey KB, Strakowski SM. Factors associated with medication adherence in African American and white patients with bipolar disorder. J Clin Psychiatry. 2005;66(5):646–52.

    Article  PubMed  Google Scholar 

  26. Carson NJ, Vesper A, Chen CN, Lê Cook B. Quality of follow-up after hospitalization for mental illness among patients from racial-ethnic minority groups. Psychiatr Serv. 2014;65(7):888–96.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Breland JY, Chee CP, Zulman DM. Racial differences in chronic conditions and sociodemographic characteristics among high-utilizing veterans. J Racial Ethn Health Dispar. 2015;2(2):167–75.

    Article  Google Scholar 

  28. Hamilton JE, Passos IC, de Azevedo Cardoso T, Jansen K, Allen M, Begley CE, Soares JC, Kapczinski F. Predictors of psychiatric readmission among patients with bipolar disorder at an academic safety-net hospital. Aust N Z J Psychiatry. 2016;50(6):584–93.

    Article  PubMed  Google Scholar 

  29. Lagerberg TV, Andreassen OA, Ringen PA, Berg AO, Larsson S, Agartz I, Sundet K, Melle I. Excessive substance use in bipolar disorder is associated with impaired functioning rather than clinical characteristics: a descriptive study. BMC Psychiatry. 2010;27(10):9.

    Article  Google Scholar 

  30. Campbell NL, Boustani MA, Skopelja EN, Gao S, Unverzagt FW, Murray MD. Medication adherence in older adults with cognitive impairment: a systematic evidence-based review. Am J Geriatr Pharmacother. 2012;10(3):165–77.

    Article  PubMed  Google Scholar 

  31. Lala SV, Sajatovic M. Medical and psychiatric comorbidities among elderly individuals with bipolar disorder: a literature review. J Geriatr Psychiatry Neurol. 2012;25(1):20–5.

    Article  PubMed  Google Scholar 

  32. Brennan P, Nichols K, Moos R. Long-term use of VA mental health services by older patient with substance use disorders. Psychiatr Serv. 2002;53:836–41.

    Google Scholar 

  33. McGinty EE, Goldman HH, Pescosolido B, Barry CL. Portraying mental illness and drug addiction as treatable health conditions: effects of a randomized experiment on stigma and discrimination. Soc Sci Med. 2015;126:73–85.

    Article  PubMed  Google Scholar 

  34. Bommersbach TJ, Lapid MI, Rummans TA, Morse RM. Geriatric alcohol use disorder: a review for primary care physicians. Mayo Clin Proc. 2015;90(5):659–66.

    Article  PubMed  Google Scholar 

  35. DeMers S, Dinsio K, Carlson W. Psychiatric care of the older adult: an overview for primary care. Med Clin N Am. 2014;98(5):1145–68.

    Article  PubMed  Google Scholar 

  36. Gfroerer M, Penne M, Pemberton M, et al. Substance abuse treatment need among older adults in 2020: the impact of the aging baby-boom cohort. Drug Alcohol Depend. 2002;69:127–35.

    Article  Google Scholar 

  37. Ostacher MJ, Perlis R, Nierenberg AA, et al. Impact of substance use disorders on recovery from episodes of depression in bipolar patients: prospective data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry. 2010;167:289–97.

    Article  PubMed  Google Scholar 

  38. Keck PE, McElroy S, Strakowski S, et al. 12-month outcome of patients with bipolar disorder following hospitalization for man or mixed episode. Am J Psychiatry. 1998;155:646–52.

    Article  PubMed  Google Scholar 

  39. Strakowski SM, DelBello MP, Fleck DE, et al. The impact of substance abuse on the course of bipolar disorder. Biol Psychiatry. 2000;48:477–85.

    Article  CAS  PubMed  Google Scholar 

  40. Hawton K, Sutton L, Haw C, et al. Suicide and attempted suicide in bipolar disorder: a systematic review or risk factors. J Clin Psychiatry. 2005;66:693–704.

    Article  PubMed  Google Scholar 

  41. Goldberg JF, Garno JL, Leon AC. A history substance abuse complicates remission form acute mania in bipolar disorder. J Clin Psychiatry. 1999;60:733–40.

    Article  CAS  PubMed  Google Scholar 

  42. Paykel E, Abbott R, Morriss R. Subsyndromal and syndromal symptoms in the longitudinal course of bipolar disorder Br J Psychiatry. 2006;189:117–23.

    Article  Google Scholar 

  43. Kessing LV, Vradi E, Andersen PK. Life expectancy in bipolar disorder. Bipolar Disord. 2015;17(5):543–8.

    Article  PubMed  Google Scholar 

  44. Hjorthøj C, Østergaard ML, Benros ME, Toftdahl NG, Erlangsen A, Andersen JT, Nordentoft M. Association between alcohol and substance use disorders and all-cause and cause-specific mortality in schizophrenia, bipolar disorder, and unipolar depression: a nationwide, prospective, register-based study. Lancet Psychiatry. 2015;2(9):801–8.

    Article  PubMed  Google Scholar 

  45. Miller C, Bauer MS. Excess mortality in bipolar disorders. Curr Psychiatry Rep. 2014;16(11):499.

    Article  PubMed  Google Scholar 

  46. Carra G, Bartoli F, Crocamo C. Attempted suicide in people with co-occurring bipolar and substance use disorders: Systematic review and meta-analysis. J Affect Disord. 2014;167:125–35.

    Article  PubMed  Google Scholar 

  47. Dalton EJ, Cate-Carter TD, Mundo E, Parikh SV, Kennedy JL. Suicide risk in bipolar patients: the role of co-morbid substance use disorders. Bipolar Disord. 2003;5(1):58–61.

    Article  PubMed  Google Scholar 

  48. Watkins HB, Meyer TD. Is there an empirical link between impulsivity and suicidality in bipolar disorders? A review of the current literature and the potential psychological implications of the relationship. Bipolar Disord. 2013;15(5):542–58.

    Article  PubMed  Google Scholar 

  49. Kiosses DN, Szanto K, Alexopoulos GS. Suicide in older adults: the role of emotions and cognition. Curr Psychiatry Rep. 2014;16(11):495.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Choi JW, Cha B, Jang J, Park CS, Kim BJ, Lee CS, Lee SJ. Resilience and impulsivity in euthymic patients with bipolar disorder. J Affect Disord. 2015;1(170):172–7.

    Article  Google Scholar 

  51. Tse S, Murray G, Chung KF, Davidson L, Ng KL, Yu CH. Exploring the recovery concept in bipolar disorder: a decision tree analysis of psychosocial correlates of recovery stages. Bipolar Disord. 2014;16(4):366–77.

    Article  PubMed  Google Scholar 

  52. Aas M, Henry C, Andreassen OA, Bellivier F, Melle I, Etain B. The role of childhood trauma in bipolar disorders. Int J Bipolar Disord. 2016;4(1):2.

    Article  PubMed  PubMed Central  Google Scholar 

  53. Fovet T, Geoffroy PA, Vaiva G, Adins C, Thomas P, Amad A. Individuals with bipolar disorder and their relationship with the criminal justice system: a critical review. Psychiatr Serv. 2015;66(4):348–53.

    Article  PubMed  Google Scholar 

  54. Oslin DW. Evidence-based treatment of geriatric substance abuse. Psychiatr Clin N Am. 2005;28(4):897–911.

    Article  Google Scholar 

  55. Substance abuse among older adults. Treatment Improvement Protocol (TIP) Series 26. Rockville, MD: SAMHSA; 2012.

    Google Scholar 

  56. Kano MY, Santos MA, Pillon SC. Use of alcohol in the elderly: transcultural validation of the Michigan Alcoholism Screening Test-Geriatric Version (MAST-G). Rev Esc Enferm USP. 2014;48(4):648–55.

    Article  PubMed  Google Scholar 

  57. Tolliver BK, Densantis SM, Brown DG, et al. A randomized, double blind, placebo controlled clinical trial of acamprosate in alcohol dependent individuals with bipolar disorder. A preliminary report. Bipolar Disord. 2012;14:54–63.

    Article  CAS  PubMed  Google Scholar 

  58. Vornik LA, Brown ES. Management of comorbid bipolar disorder and substance abuse. J Clin Psychiatry. 2006;67(Suppl 7):24–30.

    PubMed  Google Scholar 

  59. Carroll KM, Onken LS. Behavioral therapies for drug abuse. Am J Psychiatry. 2005;162(8):1452–60.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Kelley TM, Daley DC. Integrated treatment of substance use and psychiatric disorder. Soc Work Public Health. 2013;28:388–406.

    Article  Google Scholar 

  61. Wenze SJ, Gaudiano BA, Weinstock LM, Tezanos KM, Miller IW. Adjunctive psychosocial intervention following hospital discharge for patients with bipolar disorder and comorbid substance use: a pilot randomized controlled trial. Psychiatry Res. 2015;228(3):516–25.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Frye M, Salloum IM. Bipolar disorder and comorbid alcoholism: prevalence rate and treatment considerations. Bipolar Disord. 2006;8:677–85.

    Article  CAS  PubMed  Google Scholar 

  63. Singh J, Zarate CA. Pharmacological treatment of psychiatric comorbidity in bipolar disorder: a review of controlled studies. Bipolar Disord. 2006;8:677–85.

    Article  Google Scholar 

  64. Salloum IM, Cornelius JR, Daley DC, Kirisci L, Himmelhoch JM, Thase ME. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study. Arch Gen Psychiatry. 2005;62(1):37–45.

    Article  CAS  PubMed  Google Scholar 

  65. Kemp D, Gai J, Gabict S, et al. A 6 month double-blind maintenance trial of lithium monotherapy vs the combination of lithium and divalproex for rapid-cycling bipolar disorder and co-occurring substance abuse or dependence. J Clin Psychiatry. 2009;70:113–21.

    Google Scholar 

  66. Brown ES, Garza M, Carmody TJ. A randomized double blind, placebo-controlled add on trial of quetiapine in outpatients with bipolar disorder and alcohol use disorders. J Clin Psychiatry. 2008;69:701–4.

    Article  CAS  PubMed  Google Scholar 

  67. Stedman M, Pettinati H, Brown ES, et al. A double blind placebo controlled study with quetiapine as adjunctive therapy with lithium or divalproex in bipolar I patients with co-existing alcohol dependence. Alcohol Clin Exp Res. 2010;34:1822–31.

    Google Scholar 

  68. Brown ES, Carmody TJ, Schmitz JM, et al. A randomized double blind, placebo-controlled pilot study of naltrexone in outpatients with bipolar disorder and alcohol dependence. Alcohol Clin Exp Res. 2009;33:1863–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Tolliver B, McRae A, Sonne SC. Safety and tolerability of acamprosate in alcohol dependent individuals with bipolar disorder. Addict Disord Ther Treat. 2009;8:33–8.

    Article  Google Scholar 

  70. Litten RZ, Wilford BB, Falk DE, Ryan ML, Fertig JB. Potential medications for the treatment of alcohol use disorder: an evaluation of clinical efficacy and safety. Subst Abus. 2016;37(2):286–98.

    Article  PubMed  Google Scholar 

  71. Sylvia L, Gold A, Stange J. Brief report: a randomized, placebo controlled proof of concept trial of adjunctive topiramate for alcohol use disorders. Am J Addict. 2016;25:94–8.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Green CA, Yarborough MT, Polen MR, Janoff SL, Yarborough BJ. Dual recovery among people with serious mental illnesses and substance problems: a qualitative analysis. J Dual Diagn. 2015;11(1):33–41.

    Article  PubMed  Google Scholar 

  73. Schonfeld L, Dupree LW, Dickson-Euhrmann E, Royer CM, McDermott CH, Rosansky JS, Taylor S, Jarvik LF. Cognitive-behavioral treatment of older veterans with substance abuse problems. J Geriatr Psychiatry Neurol. 2000;13(3):124–9.

    Article  CAS  PubMed  Google Scholar 

  74. Schmitz A, Grillion C. Assessing fear and anxiety in humans using the threat of predictable and unpredictable aversive events (the NPU-threat test). Nat Protoc. 2012;7(3):527–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  75. Weiss RD, Griffin ML, Jaffee WB, Bender RE, Graff FS, Gallop RJ, Fitzmaurice GM. A “community-friendly” version of integrated group therapy for patients with bipolar disorder and substance dependence: a randomized controlled trial. Drug Alcohol Depend. 2009;104(3):212–9.

    Article  PubMed  PubMed Central  Google Scholar 

  76. Holroyd S, Duryee JJ. Substance use disorders in a geriatric psychiatry outpatient clinic: prevalence and epidemiologic characteristics. J Nerv Ment Dis. 1997;185(10):627–32.

    Article  CAS  PubMed  Google Scholar 

  77. Egan M, Moride Y, Wolfson C, Monette J. Long-term continuous use of benzodiazepines by older adults in Quebec: prevalence, incidence and risk factors. J Am Geriatr Soc. 2000;48(7):811–6.

    Article  CAS  PubMed  Google Scholar 

  78. Petrovic M, Vandierendonck A, Mariman A, van Maele G, Afschrift M, Pevernagie D. Personality traits and socio-epidemiological status of hospitalized elderly benzodiazepine users. Int J Geriatr Psychiatry. 2002;17(8):733–8.

    Google Scholar 

  79. Alvarenga JM, Loyola Filho AI, Firmo JO, Lima-Costa MF, Uchoa E. Prevalence and sociodemographic characteristics associated with benzodiazepines use among community dwelling older adults: the Bambuí Health and Aging Study (BHAS). Rev Bras Psiquiatr. 2008;30(1):7–11.

    Article  PubMed  Google Scholar 

  80. Vázquez GH, Baldessarini RJ, Tondo L. Co-occurrence of anxiety and bipolar disorders: clinical and therapeutic overview. Depress Anxiety. 2014;31(3):196–206.

    Article  PubMed  CAS  Google Scholar 

  81. Finfgeld-Connett DL. Treatment of substance misuse in older women: using a brief intervention model. J Gerontol Nurs. 2004;30(8):30–7.

    Article  PubMed  Google Scholar 

  82. Hill-Taylor B, Sketris IS, Gardner DM, Thompson K. Concordance with a STOPP (Screening Tool of Older Persons’ Potentially Inappropriate Prescriptions) criterion in Nova Scotia, Canada: benzodiazepine and zoplicone prescription claims by older adults with fall-related hospitalizations. J Popul Ther Clin Pharmacol. 2016;23(1):e1–12.

    CAS  PubMed  Google Scholar 

  83. Lin SK. Rapid detoxification of benzodiazepine or Z-drugs dependence using acetylcholinesterase inhibitors. Med Hypotheses. 2014;83(1):108–10.

    Article  CAS  PubMed  Google Scholar 

  84. Kawasaki SS, Jacapraro JS, Rastegar DA. Safety and effectiveness of a fixed-dose phenobarbital protocol for inpatient benzodiazepine detoxification. J Subst Abuse Treat. 2012;43(3):331–4.

    Article  PubMed  Google Scholar 

  85. Croissant B, Diehl A, Klein O, Zambrano S, Nakovics H, Heinz A, Mann K. A pilot study of oxcarbazepine versus acamprosate in alcohol-dependent patients. Alcohol Clin Exp Res. 2006;30(4):630–5.

    Article  CAS  PubMed  Google Scholar 

  86. Shaw GK. Detoxification: the use of benzodiazepines. Alcohol. 1995;30(6):765–70.

    Google Scholar 

  87. Treatment Improvement Protocol (TIP) Series, No. 45. Center for Substance Abuse Treatment. Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2006.

    Google Scholar 

  88. Cregler LL, Mark H. Medical complications of cocaine abuse. N Engl J Med. 1986;315(23):1495–500.

    Article  CAS  PubMed  Google Scholar 

  89. Morton WA. Cocaine and psychiatric symptoms. Prim Care Companion J Clin Psychiatry. 1999;1(4):109–13.

    Article  PubMed  PubMed Central  Google Scholar 

  90. Rivers E, Shirazi E, Aurora T, Mullen M, Gunnerson K, Sheridan B, Eichhorn L, Tomlanovich M. Cocaine use in elder patients presenting to an inner-city emergency department. Acad Emerg Med. 2004;11(8):874–7.

    Article  PubMed  Google Scholar 

  91. Cameron P, Jellinik G, Kelly AM, Brown A, Little M (eds). Textbook of adult emergency medicine. 4th ed. London: Churchill Livingston; 2014.

    Google Scholar 

  92. Prochaska JO, Velicer WF, Rossi JS, Goldstein MG, Marcus BH, Rakowski W, Fiore C, Harlow LL, Redding CA, Rosenbloom D. Stages of change and decisional balance for 12 problem behaviors. Health Psychol. 1994;13(1):39–46.

    Article  CAS  PubMed  Google Scholar 

  93. Brown ES, Gorman AR, Hynan LS. A randomized, placebo-controlled trial of citicoline add-on therapy in outpatients with bipolar disorder and cocaine dependence. J Clin Psychopharmacol. 2007;27(5):498–502.

    Article  CAS  PubMed  Google Scholar 

  94. Brown ES, Perantie DC, Dhanani N, Beard L, Orsulak P, Rush AJ. Lamotrigine for bipolar disorder and comorbid cocaine dependence: a replication and extension study. J Affect Disord. 2006;93(1–3):219–22.

    Article  CAS  PubMed  Google Scholar 

  95. Brown ES, Nejtek VA, Perantie DC, Orsulak PJ, Bobadilla L. Lamotrigine in patients with bipolar disorder and cocaine dependence. J Clin Psychiatry. 2003;64(2):197–201.

    Article  CAS  PubMed  Google Scholar 

  96. Brown ES, Todd JP, Hu LT, Schmitz JM, Carmody TJ, Nakamura A, Sunderajan P, Rush AJ, Adinoff B, Bret ME, Holmes T, Lo A. A randomized, double-blind, placebo-controlled trial of citicoline for cocaine dependence in bipolar I disorder. Am J Psychiatry. 2015;172(10):1014–21.

    Article  PubMed  Google Scholar 

  97. Yee T, Perantie DC, Dhanani N, Brown ES. Drug dreams in outpatients with bipolar disorder and cocaine dependence. J Nerv Ment Dis. 2004;192(3):238–42.

    Article  PubMed  Google Scholar 

  98. Brown ES, Nejtek VA, Perantie DC, Bobadilla L. Quetiapine in bipolar disorder and cocaine dependence. Bipolar Disord. 2002;4(6):406–11.

    Article  CAS  PubMed  Google Scholar 

  99. Khantzian EJ, Albanese MJ. Self-medication, bipolar disorders, and stimulant dependence. J Clin Psychiatry. 2009;70(6):935–6 (author reply 936-7).

    Article  PubMed  Google Scholar 

  100. Klassen LJ, Katzman MA, Chokka PJ. Adult ADHD and its comorbidities, with a focus on bipolar disorder. J Affect Disord. 2010;124(1–2):1–8.

    Article  PubMed  Google Scholar 

  101. McElroy SL, Martens BE, Mori N, Blom TJ, Casuto LS, Hawkins JM, Keck PE Jr. Adjunctive lisdexamfetamine in bipolar depression: a preliminary randomized, placebo-controlled trial. Int Clin Psychopharmacol. 2015;30(1):6–13.

    Article  PubMed  Google Scholar 

  102. Abbasowa Vinberg M. Psychostimulants in moderate to severe affective disorder: a systematic review of randomized controlled trials. Nord J Psychiatry. 2013;67(6):369–82.

    Article  PubMed  Google Scholar 

  103. Chengappa KN, Levine J, Gershon S, Kupfer DJ. Lifetime prevalence of substance or alcohol abuse and dependence among subjects with bipolar I and II disorders in a voluntary registry. Bipolar Disord. 2000;2(3 Pt 1):191–5.

    Article  CAS  PubMed  Google Scholar 

  104. Shoptaw S, Peck J, Reback CJ, Rotheram-Fuller E. Psychiatric and substance dependence comorbidities, sexually transmitted diseases, and risk behaviors among methamphetamine-dependent gay and bisexual men seeking outpatient drug abuse treatment. J Psychoactive Drugs. 2003;35(Suppl 1):161–8.

    Article  PubMed  Google Scholar 

  105. Silverstone PH, Asghar SJ, O’Donnell T, Ulrich M, Hanstock CC. Lithium and valproate protect against dextro-amphetamine induced brain choline concentration changes in bipolar disorder patients. World J Biol Psychiatry. 2004;5(1):38–44.

    Article  PubMed  Google Scholar 

  106. McDonell MG, Srebnik D, Angelo F, McPherson S, Lowe JM, Sugar A, Short RA, Roll JM, Ries RK. Randomized controlled trial of contingency management for stimulant use in community mental health patients with serious mental illness. Am J Psychiatry. 2013;170(1):94–101.

    Article  PubMed  PubMed Central  Google Scholar 

  107. Brown ES, Gabrielson B. A randomized, double-blind, placebo-controlled trial of citicoline for bipolar and unipolar depression and methamphetamine dependence. J Affect Disord. 2012;143(1–3):257–60.

    Article  CAS  PubMed  Google Scholar 

  108. Nejtek VA, Avila M, Chen LA, Zielinski T, Djokovic M, Podawiltz A, Kaiser K, Bae S, Rush AJ. Do atypical antipsychotics effectively treat co-occurring bipolar disorder and stimulant dependence? A randomized, double-blind trial. J Clin Psychiatry. 2008;69(8):1257–66.

    Article  CAS  PubMed  Google Scholar 

  109. Sehgal N, Manchikanti L, Smith HS. Prescription opioid abuse in chronic pain: a review of opioid abuse predictors and strategies to curb opioid abuse. Pain Physician. 2012;15(3 Suppl):ES67–92.

    PubMed  Google Scholar 

  110. Martins SS, Fenton MC, Keyes KM, Blanco C, Zhu H, Storr CL. Mood and anxiety disorders and their association with non-medical prescription opioid use and prescription opioid-use disorder: longitudinal evidence from the National Epidemiologic Study on Alcohol and Related Conditions. Psychol Med. 2012;42(6):1261–72.

    Article  CAS  PubMed  Google Scholar 

  111. Shabani A, Jolfaei AG, Vazmalaei HA, Ebrahimi AA, Naserbakht M. Clinical and course indicators of bipolar disorder type I with and without opioid dependence. J Res Med Sci. 2010;15(1):20–6.

    PubMed  PubMed Central  Google Scholar 

  112. Albanese MJ, Clodfelter RC Jr, Pardo TB, Ghaemi SN. Underdiagnosis of bipolar disorder in men with substance use disorder. J Psychiatr Pract. 2006;12(2):124–7.

    Article  PubMed  Google Scholar 

  113. Shariat SV, Hosseinifard Z, Taban M, Shabani A. Mania precipitated by opioid withdrawal: a retrospective study. Am J Addict. 2013;22(4):338–43.

    Article  PubMed  Google Scholar 

  114. Back SE, Lawson KM, Singleton LM, Brady KT. Characteristics and correlates of men and women with prescription opioid dependence. Addict Behav. 2011;36(8):829–34.

    Article  PubMed  PubMed Central  Google Scholar 

  115. Kolodziej ME, Griffin ML, Najavits LM, Otto MW, Greenfield SF, Weiss RD. Anxiety disorders among patients with co-occurring bipolar and substance use disorders. Drug Alcohol Depend. 2005;80(2):251–7.

    Article  PubMed  Google Scholar 

  116. Rudd RA, Aleshire N, Zibbell JE, Gladden RM. Increases in drug and opioid overdose deaths-United States, 2000–2014. MMWR Morb Mortal Wkly Rep. 2016;64(50–51):1378–82.

    Article  PubMed  Google Scholar 

  117. Zedler B, Xie L, Wang L, Joyce A, Vick C, Kariburyo F, Rajan P, Baser O, Murrelle L. Risk factors for serious prescription opioid-related toxicity or overdose among Veterans Health Administration patients. Pain Med. 2014;15(11):1911–29.

    Article  PubMed  Google Scholar 

  118. Cerimele JM, Chwastiak LA, Dodson S, Katon WJ. The prevalence of bipolar disorder in general primary care samples: a systematic review. Gen Hosp Psychiatry. 2014;36(1):19–25.

    Article  PubMed  Google Scholar 

  119. Ryan R, Santesso N, Lowe D, Hill S, Grimshaw J, Prictor M, Kaufman C, Cowie G, Taylor M. Interventions to improve safe and effective medicines use by consumers: an overview of systematic reviews. Cochrane Database Syst Rev. 2014;4:CD007768.

    Google Scholar 

  120. Belgrade MJ, Schamber CD, Lindgren BR. The DIRE score: predicting outcomes of opioid prescribing for chronic pain. J Pain. 2006;7(9):671–81.

    Article  PubMed  Google Scholar 

  121. Just J, Mücke M, Bleckwenn M. Dependence on prescription opioids. Dtsch Arztebl Int. 2016;113(13):213–20.

    PubMed  PubMed Central  Google Scholar 

  122. Gold MS, Pottash AC, Sweeney D, Martin D, Extein I. Antimanic, antidepressant, and antipanic effects of opiates: clinical, neuroanatomical, and biochemical evidence. Ann NY Acad Sci. 1982;398:140–50.

    Article  CAS  PubMed  Google Scholar 

  123. Olive MF, Cleva RM, Kalivas PW, Malcolm RJ. Glutamatergic medications for the treatment of drug and behavioral addictions. Pharmacol Biochem Behav. 2012;100(4):801–10.

    Article  CAS  PubMed  Google Scholar 

  124. Brown R. Heroin dependence. WMJ. 2004;103(4):20–6.

    PubMed  Google Scholar 

  125. Woodcock EA, Lundahl LH, Stoltman JJ, Greenwald MK. Progression to regular heroin use: examination of patterns, predictors, and consequences. Addict Behav. 2015;45:287–93.

    Article  PubMed  Google Scholar 

  126. Fareed A, Casarella J, Amar R, Vayalapalli S, Drexler K. Benefits of retention in methadone maintenance and chronic medical conditions as risk factors for premature death among older heroin addicts. J Psychiatr Pract. 2009;15(3):227–34.

    Article  PubMed  Google Scholar 

  127. Han B, Polydorou S, Ferris R, Blaum CS, Ross S, McNeely J. Demographic trends of adults in New York City opioid treatment programs—an aging population. Subst Use Misuse. 2015;50(13):1660–7.

    Article  PubMed  Google Scholar 

  128. Heffner JL, DelBello MP, Fleck D, et al. Cigarette smoking in the early course of bipolar disorder: association with ages-at onset of alcohol and marijuana use. Bipolar Disord. 2008;10:838–45.

    Article  PubMed  Google Scholar 

  129. Leite RT, Nogueira Sde O, do Nascimento JP, de Lima LS, da Nóbrega TB, Virgínio Mda S, Moreno LM, Sampaio BH, de Matos E, Souza FG. The use of cannabis as a predictor of early onset of bipolar disorder and suicide attempts. Neural Plast. 2015;2015:434127.

    PubMed  PubMed Central  Google Scholar 

  130. Fattore L. Synthetic cannabinoids—further evidence supporting the relationship between cannabinoids and psychosis. Biol Psychol. 2016;79(7):539–48.

    Article  CAS  Google Scholar 

  131. Castaneto M, Gorelick D, Desrosiers N, Hartman T, Pirard S, Huestis M. Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications. Drug Alcohol Depend. 2014;1(144):12–41.

    Article  CAS  Google Scholar 

  132. Reinarman C, Nunberg H, Lanthier F, Heddleston T. Who are medical marijuana patients? Population characteristics from nine California assessment clinics. J Psychoactive Drugs. 2011;43(2):128–35.

    Article  PubMed  Google Scholar 

  133. Miller PG, Sønderlund AL. Using the internet to research hidden populations of illicit drug users: a review. Addiction. 2010;105(9):1557–67.

    Article  PubMed  Google Scholar 

  134. Kim S, Dodd S, Berk L, Kulkarni J, de Castella A, Fitzgerald PB, Kim JM, Yoon JS, Berk M. Impact of cannabis use on long-term remission in bipolar I and schizoaffective disorder. Psychiatry Investig. 2015;12(3):349–55.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  135. Danovitch I, Gorelick DA. State of the art treatments for cannabis dependence. Psychiatr Clin N Am. 2012;35(2):309–26.

    Article  Google Scholar 

  136. Marshall K, Gowing L, Ali R, Le Foll B. Pharmacotherapies for cannabis dependence. Cochrane Database Syst Rev. 2014;12:CD008940.

    Google Scholar 

  137. Allsop DJ, Lintzeris N, Copeland J, Dunlop A, McGregor IS. Cannabinoid replacement therapy (CRT): nabiximols (Sativex) as a novel treatment for cannabis withdrawal. Clin Pharmacol Ther. 2015;97(6):571–4.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. 35 Morrill Street, West Newton, MA, 02465, USA

    Chaya Bhuvaneswaran

  2. 4338 Leach St, Oakland, CA, 94602, USA

    Rita Hargrave

  3. Department of Psychiatry, The University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, MC 8849, Dallas, TX, 75390-8849, USA

    E. Sherwood Brown

Authors
  1. Chaya Bhuvaneswaran
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rita Hargrave
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. Sherwood Brown
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to E. Sherwood Brown .

Editor information

Editors and Affiliations

  1. School of Medicine, The Johns Hopkins University School of Medicine, BALTIMORE, Maryland, USA

    Susan W. Lehmann

  2. Department of Psychiatry, McLean Hospital Harvard Medical School, Belmont, Massachusetts, USA

    Brent P. Forester

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Bhuvaneswaran, C., Hargrave, R., Sherwood Brown, E. (2017). Older Age Bipolar Disorder and Substance Use. In: Lehmann, S., Forester, B. (eds) Bipolar Disorder in Older Age Patients. Springer, Cham. https://doi.org/10.1007/978-3-319-48912-4_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-48912-4_5

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-48910-0

  • Online ISBN: 978-3-319-48912-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation